Healthcare Professionals
Please log in for special information and services
Tamás Demeter Country Manager Hungary

“Since 2007 our agile and motivated Hungarian team has been consolidating its competencies to deliver treatment options for patients with rare diseases! Mutual appreciation and commitment are the keys to our success!"

Facts & Figures

AOP Orphan is fully dedicated to pharmaceutical and clinical development as well as commercialization of drugs for more than 20 years already.

Our motivation at AOP Orphan is to help patients who suffer from rare diseases. We achieve this cooperating with stakeholders of the Hungarian health care system. Partnerships within pharmaceutical and health care industry are crucial for finding and providing solutions for patients, especially in the treatment of orphan diseases. 

Hungary occupies a special position among many countries where AOP Orphan is represented. In this market, the company began its development in 2007. AOP Orphan Hungary is a team of six employees in the Marketing & Sales, and Medical for all three therapeutic divisions.

485,000 
people
PATIENTS WITH RARE DISEASES IN hungary
In Europe those diseases that occur in less than 5 per 10,000 residents are defined as rare diseases. In Hungary 485,000 people have been diagnosed with a rare disease.
AVAILABLE TREATMENTS
In Hungary AOP Orphan provides seven products. 
 
7
products
3
areas
THREE THERAPEUTIC AREAS
AOP Orphan Austria covers three area of treatments: HematoOncology, Cardiology & Pulmonology, Neurology and Metabolic Disorders.

Vision & Mission

Milestones